ESMO Clinical Practice Guidelines: Endocrine and Neuroendocrine Cancers

The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.

Latest enhanced and revised set of guidelines

ESMO has two Clinical Practice Guidelines on Endocrine Cancers: Adrenal Cancer and Thyroid Cancer including differentiated thyroid cancer, medullary thyroid cancer, poorly differentiated thyroid cancer and anaplastic thyroid cancer.  They include information on: incidence, diagnosis, staging and risk assessment, treatment response evaluation and follow-up.